Akt acts as a switch for GPCR transactivation of the TGF-ß receptor type 1.

Mohamed, Raafat; Shajimoon, Aravindra; Afroz, Rizwana; Gabr, Mai; Thomas, Walter G; Little, Peter J; Kamato, Danielle

Mohamed, Raafat; Shajimoon, Aravindra; Afroz, Rizwana; Gabr, Mai; Thomas, Walter G; Little, Peter J; Kamato, Danielle.

Affiliation

Mohamed R; School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, Australia.
Shajimoon A; School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, Australia.
Afroz R; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, Australia.
Gabr M; School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, Australia.
Thomas WG; School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, Australia.
Little PJ; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, Australia.
Kamato D; School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, Australia.

FEBS J ; 289(9): 2642-2656, 2022 05.

Article in En | MEDLINE | ID: mdl-34826189

Subject(s)
Key words

SC79; Smad; angiotensin II; thrombin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombin / Proto-Oncogene Proteins c-akt / Receptor, Transforming Growth Factor-beta Type I Type of study: Prognostic_studies Limits: Humans Language: En Journal: FEBS J Journal subject: BIOQUIMICA Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google